Imbalance Between Interleukin-1β and Interleukin-1 Receptor Antagonist in Epicardial Adipose Tissue Is Associated With Non ST-Segment Elevation Acute Coronary Syndrome | Zendy

Valentina Parisi | Zendy; Laura Petraglia | Zendy; Serena Cabaro | Zendy; Vittoria D’Esposito | Zendy; Dario Bruzzese | Zendy; Giusy Ferraro | Zendy; Andrea Urbani | Zendy; Fabrizio Vincenzo Grieco | Zendy; Maddalena Conte | Zendy; Aurelio Caruso | Zendy; Maria Grimaldi | Zendy; Antonio De Bellis | Zendy; Salvatore Severino | Zendy; Pasquale Campana | Zendy; Emanuele Pilato | Zendy; Giuseppe Comentale | Zendy; Maddalena Raia | Zendy; Giulia Scalia | Zendy; Giuseppe Castaldo | Zendy; Pietro Formisano | Zendy; Dario Leosco | Zendy

Open Access

Imbalance Between Interleukin-1β and Interleukin-1 Receptor Antagonist in Epicardial Adipose Tissue Is Associated With Non ST-Segment Elevation Acute Coronary Syndrome

Author(s) -

Valentina Parisi,

Laura Petraglia,

Serena Cabaro,

Vittoria D’Esposito,

Dario Bruzzese,

Giusy Ferraro,

Andrea Urbani,

Fabrizio Vincenzo Grieco,

Maddalena Conte,

Aurelio Caruso,

Maria Grimaldi,

Antonio De Bellis,

Salvatore Severino,

Pasquale Campana,

Emanuele Pilato,

Giuseppe Comentale,

Maddalena Raia,

Giulia Scalia,

Giuseppe Castaldo,

Pietro Formisano,

Dario Leosco

Publication year - 2020

Publication title -

frontiers in physiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.32

H-Index - 102

ISSN - 1664-042X

DOI - 10.3389/fphys.2020.00042

Subject(s) - medicine , adipose tissue , interleukin 1 receptor antagonist , acute coronary syndrome , pathogenesis , coronary artery disease , interleukin , receptor antagonist , population , gastroenterology , endocrinology , artery , antagonist , cardiology , receptor , cytokine , myocardial infarction , environmental health

Interleukin-1beta (IL-1β) is crucially involved in the pathogenesis of coronary atherosclerotic diseases (CAD) and its inhibition has proven cardiovascular benefits. Epicardial adipose tissue (EAT) is a local source of inflammatory mediators which may negatively affect the surrounding coronary arteries. In the present study, we explored the relationship between serum and EAT levels of IL-1β and IL-1 receptor antagonist (IL-1ra) in patients with chronic coronary syndrome (CCS) and recent acute coronary syndrome (ACS). Methods We obtained EAT biopsies in 54 CCS (Group 1) and 33 ACS (Group 2) patients undergoing coronary artery bypass grafting. Serum and EAT levels of IL-1β and IL-1ra were measured in all patients. An immunophenotypic study was carried out on EAT biopsies and the CD86 events were studied as markers of M1 macrophages. Results Circulating levels of IL-1β were significantly higher in the overall CAD population compared to a control group [7.64 pg/ml (6.86; 8.57) vs. 1.89 pg/ml (1.81; 2.29); p < 0.001]. In contrast, no differences were observed for serum IL-1ra levels between CAD and controls. Comparable levels of serum IL-1β were found between Groups 1 and 2 [7.6 pg/ml (6.9; 8.7) vs. 7.9 pg/ml (7.2; 8.6); p = 0.618]. In contrast, significantly lower levels of serum IL-1ra were found in Group 2 compared to Group 1 [274 pg/ml (220; 577) vs. 603 pg/ml (334; 1022); p = 0.035]. No differences of EAT levels of IL-1β were found between Group 2 and Group 1 [3.4 pg/ml (2.3; 8.4) vs. 2.4 pg/ml (1.9; 8.0); p = 0.176]. In contrast, significantly lower EAT levels of IL-1ra were found in Group 2 compared to Group 1 [101 pg/ml (40; 577) vs. 1344 pg/ml (155; 5327); p = 0.002]. No correlation was found between EAT levels of IL-1β and CD86 and CD64 events. Conclusion The present study explores the levels of IL-1β and IL-1ra in the serum and in EAT of CCS and ACS patients. ACS seems to be associated to a loss of the counter-regulatory activity of IL-1ra against the pro-inflammatory effects related to IL-1β activation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research